LAVA Therapeutics NV Capital Reinvestment Ratio
LAVA Therapeutics NV capital reinvestment ratio. LAVA Therapeutics NV (LVTX) has a Capital Reinvestment Ratio of 0.01x as of December 2022, meaning it reinvests 0% of its operating cash flow ($35.73 Million) in capital expenditures ($265.00K). Check LAVA Therapeutics NV (LVTX) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of LAVA Therapeutics NV (2022–2022)
Capital reinvestment ratio of LAVA Therapeutics NV from 2022 to 2022. This chart tracks LAVA Therapeutics NV's Capital Reinvestment Ratio across 1 annual periods. Also explore net asset growth rate of LAVA Therapeutics NV to track the company's year-over-year net asset growth rate.
LAVA Therapeutics NV Capital Reinvestment Ratio by Year (2022–2022)
LAVA Therapeutics NV capital reinvestment ratio by year from 2022 to 2022. For the full cash flow conversion analysis, see LVTX cash generation efficiency.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.15x | $4.04 Million | $587.00K | — |